Cartesian Therapeutics In... (RNAC)
NASDAQ: RNAC
· Real-Time Price · USD
12.33
0.33 (2.75%)
At close: May 01, 2025, 3:59 PM
12.27
-0.49%
After-hours: May 01, 2025, 04:20 PM EDT
Cartesian Therapeutics Revenue
Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending December 31, 2024, Cartesian Therapeutics generated -$759K in revenue.
Revenue (ttm)
$38.91M
Revenue Growth
49.64%
Price / Sales Ratio
71.39
Revenue / Employee
$589.59K
Employees
66
Market Cap
319.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 38.91M | +49.64% |
| Dec 31, 2023 | 26M | -76.53% |
| Dec 31, 2022 | 110.78M | +30.21% |
| Dec 31, 2021 | 85.08M | +412.60% |
| Dec 31, 2020 | 16.6M | n/a |